The Division of Hematology and Oncology offers exposure to the full spectrum
of blood disorders and malignancies of childhood. Residents play an active
role in the diagnosis and therapeutic management of children hospitalized
because of hematologic and oncologic diseases. A one-month rotation on
the service is included in the second year of residency training and additional
months are offered as elective.
Approximately 80 hematology-oncology patients are seen each week in the
outpatient department. There are generally 15 patients hospitalized on
the general hematology and oncology ward and additional patients hospitalized
in the specialized pediatric bone marrow transplant unit. A wide variety
of disorders are represented in this population including hemolytic anemia,
thalassemia, sickle cell disease, thrombocytopenia, neutropenia, hemophilia,
aplastic anemia, as well as all of the hematologic and solid tumor malignancies
of childhood. The division directs a specialized center for hemophilia
and currently follows more than 300 patients who reside in Iowa and western
Illinois.
As a member of the Children's Oncology Group, the division participates
in a wide variety of national collaborative studies for pediatric patients
with malignant disease.
The division directs and coordinates all of the pediatric bone marrow
transplant activities on an inpatient unit dedicated exclusively to pediatric
bone marrow transplantation. The primary interest of the division is in
the use of peripheral blood stem cell transplants. The unit is staffed
with attending physicians, clinical nurse practitioners, and physician
assistants, but residents have the opportunity, on an elective basis,
to rotate on the unit.
Rheumatology is a sub-section of the Division of Hematology/Oncology.
Weekly clinic, teaching conferences, and inpatient consults provide an
introduction to the rheumatic diseases of childhood. The rheumatology
outpatient clinic experience provides exposure to patients with juvenile
rheumatoid arthritis, systemic lupus erythematosus, spondylitis, dermatomyositis
and other immune mediated disorders.
Basic research programs in transitional research, neuro-oncology, the
immunobiology of malignant disease, the developmental biology of extracellular
matrix in hematopoiesis, modifications of tumor cell membranes to enhance
chemotherapy, the molecular basis of von Willebrands disease, signal
transduction in T cells and the genetic basis of autoimmune disease are
being actively pursued by various members of the division.
The fellowship program in pediatric hematology-oncology offers clinical
training, as well as general laboratory and blood banking experience,
satisfying the criteria for sub-board certification. The program is focused
on development of academic pediatric hematologists and oncologists and,
therefore, provides for the development of basic research skills during
the final two years.
Top of Page
|
Pediatrics Residency Program Home
Division of Pediatric Hematology, Oncology, Immunology, and Rheumatology
An inpatient wing of the University of Iowa Children's Hospital
|